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Available online 27 June 2016Background: There is conflicting information about sex differences in presentation, treatment, and outcome after
acute coronary syndromes (ACS) in the era of reperfusion therapy and percutaneous coronary intervention. The
aim of this study was to examine presentation, acute therapy, and outcomes of men and women with ACS with
special emphasis on their relationship with younger age (≤65 years).
Methods: From January 2010 to June 2015, we enrolled 5140 patients from 3 primary PCI capable hospitals.
Patients were registered according to the International Survey of Acute Coronary Syndrome in Transitional
Countries (ISACS-TC) registry protocol (ClinicalTrials.gov: NCT01218776). The primary outcome was the
incidence of in-hospital mortality.
Results: The study population was constituted by 2876 patients younger than 65 years and 2294 patients older.
Women were older than men in both the young (56.2 ± 6.6 vs. 54.1 ± 7.4) and old (74.9 ± 6.4 vs. 73.6 ±
6.0) age groups. There were 3421 (66.2%) patients with ST elevation ACS (STE-ACS) and 1719 (33.8%) patients
without ST elevation ACS (NSTE-ACS). In STE-ACS, the percentage of patients who failed to receive reperfusion
was higher in women than in men either in the young (21.7% vs. 15.8%) than in the elderly (35.2% vs. 29.6%).
There was a significant higher mortality in women in the younger age group (age-adjusted OR 1.52, 95% CI:
1.01–2.29), but there was no sex difference in the older group (age-adjusted OR 1.10, 95% CI: 0.87–1.41). Signif-
icantly sex differences in mortality were not seen in NSTE-ACS patients.
Conclusions: In-hospital mortality from ACS is not different between oldermen andwomen. A higher short-term
mortality can be seen only in women with STEMI and age of 65 or less.





Cardiovascular disease (CVD) is the leading cause of morbidity and
mortality in the general populationwith a trend of increased prevalence
in older patients and men [1–4]. Prevalence of CVD among women in-
creases with age, but CVD is still the highest cause of death in the youn-
ger women [5,6]. In Serbia mortality from CVD in women is one of theiversity of Belgrade, 11000
jcic).highest in the European countries [7–9]. Many studies have shown
that womenwith acute coronary syndromes (ACS) are less likely to un-
dergo cardiac catheterization, as well as to receive timely reperfusion
therapy [10,11].
The purpose of this study was to examine presentation, acute thera-
py, and short-term mortality of men and women with confirmed ACS
admitted from January 2010 to June 2015 in three PCI capable university
centers in Belgrade and Kragujevac. In these cities, social, education and
income differences betweenwomen andmen are less pronounced than
in other smaller cities or large cities but without PCI capable hospitals
special respect to the interaction of age and gender.
Table 2
Baseline characteristics STE-ACS patients andNSTE-ACS patients sortedby age andgender.
Variables Younger pts ≤ 65
(n = 2038)
Older pts N 65
(n = 1383)
STE-ACS
Gender M/W, n (%) 1530/508 (75.1/24.9) 783/600 (56.6/43.4)
Age 54.3 ± 7.4 74.1 ± 6.3
Men 53.7 ± 7.6 73.5 ± 6.1
Women 56.0 ± 6.7 74.9 ± 6.5
NSTE-ACS
Gender M/W, n (%) 602/236 (71.8/28.2) 471/440(51.7/48.3)
Age 55.5 ± 6.8 74.3 ± 6.1
Men 55.1 ± 7.0 73.9 ± 5.7
Women 56.6 ± 6.3 74.9 ± 6.4
Data are expressed as number (percentages) or mean ± SD, unless otherwise stated.
M: men; W: women; NSTE-ACS: non-ST-segment elevation acute coronary syndromes;
STE-ACS: ST-segment elevation acute coronary syndromes.
Table 3
Patients with STE-ACS compared by age.
Variable Younger pts ≤ 65
n = 2876
Older pts N 65
n = 2294
p value
STE-ACS 2038 (70.9) 1383 (60.3) b0.001
Medical history
Time from symptom onset to
admission
b6 h 1647 (65.0) 1060 (53.2) b0.001
6–12 h 225 (10.1) 243 (21.2) b0.001
N12 h 630 (24.9) 691 (34.7) b0.001
Typical chest pain 2643 (93.3) 2013 (89.3) b0.001
Killip class N1 740 (25.7) 965 (42.1) b0.001
Risk factors
Family history of CAD 1613 (59.7) 1066 (52.6) b0.001
Diabetes 585 (21.2) 803 (36.5) b0.001
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2.1. Study population
The details of the ISACS-TC registry protocol (ClinicalTrials.gov: NCT01218776) have
been previously published [12–16]. Briefly, the ISACS-TC registry is a prospective, multi-
center study devoted to developing and evaluating survey measures that elicit improved
outcomes in most transition countries embarked on reforming health systems.
Data from 3 university PCI capable hospitals in Belgrade and Kragujevac were collect-
ed from January 2010 to June 2015. We included in the analysis only patients who had
complete data on in-hospital outcomes.
2.2. Data collection
Diagnosis of myocardial infarction was adjudicated according to the international
standardized criteria [17]. Demographic data, patient history, and procedural and outcome
data were electronically recorded. Local investigatorswere instructed in detail by local co-
ordinators and bymeans of the ISACS-TC study protocol. At the data center, all case record
forms were checked for completeness and if necessary returned to the participating
hospitals for correction.
2.3. Endpoints
The primary endpoint was to asses in-hospital mortality in older (N65) and younger
(≤65) ACS patients. We presented data on clinical presentation, comorbidity, risk factors,
previous history of CVD, in hospital medications, and reperfusion therapy in ACS patients.
Subgroup analyses were performed in patients with ST elevation ACS (STE-ACS) and
without ST elevation ACS (NSTE-ACS).
2.4. Statistical analysis
Data are represented as percentages or expressed as means together with standard
deviations for continuous variables (i.e. age). Using χ2 we tested the differences between
sexes in younger and older age groups regarding patient characteristics, diagnosis, and
hospital treatment. Additionally, the same analytic strategy was applied in testing sex dif-
ferences in older and younger STE-ACS and NSTE-ACS patients. We used odds ratio (OR)
and 95% coefficient intervals (CI) to assess the association between hospital mortality
rates and gender in both age groups. Finally we used a logistic regression model in order
to investigate predictors of in-hospital mortality. Significance level was set to p b .05,
and all the analyses were performed using SPSS 16.0 (SPSS Inc., Chicago, USA) and
MedCalc 12.5 (MedCalc Software, Ostend, Belgium).
3. Results
3.1. ACS patients' characteristics classified by age, gender and diagnosis
There were 5140 patients admitted with ACS: 2876 were younger
than ≤65 years and 2294 were older than 65 years. In both groups
there were more men than women, specifically: 74.1% versus 25.9%
(p b 0.001) in younger and 54.7% versus 45.3% (p b 0.001) in the older
age group. In the younger age group, there were almost three times
more men than women, whereas the gender distribution was closer in
the older age group.Womenwere, on average, older in both age groups,
specifically 56.2 ± 6.6 versus 54.1 ± 7.4 in the younger and 74.9 ± 6
versus 73.6 ± 6.0 in the older age group (Table 1).
3.2. STE-ACS versus NSTE-ACS
There were more STE-ACS patients, than NSTE-ACS patients (3421/
66.2% versus 1749/33.8%). STE-ACS patients were younger (mean age
62.3 ± 12.1 years), than NSTE-ACS patients (65.3 ± 11.4 years)Table 1
Baseline characteristics of ACS patients sorted by age and gender.
Demographics Younger pts ≤ 65
n = 2876
Older pts N 65
n = 2294
Gender M/W 2132/744 (74.1/25.9) 1254/1040 (54.7/45.3)
Age 54.6 ± 7.3 74.2 ± 6.2
Men 54.1 ± 7.4 73.6 ± 6.0
Women 56.2 ± 6.6 74.9 ± 6.4
Data are expressed as number (percentages) or mean ± SD.
ACS: acute coronary syndromes; M: men; W: women.(Table 2). The majority of STE-ACS patients were men (67.6% versus
32.4% p b 0.001) and younger than 65 years of age (59.6% versus
40.4% p b 0.001). The NSTE-ACS patients, were relativelymore balanced
regarding the age groups (47.9% in the younger versus 52.1% in the
older, p b 0.001). Yet the NSTE-ACS group was constituted predomi-
nantly by men (61.3% versus 38.7%, p b 0.001) (Table 2).3.3. Clinical characteristics in STE-ACS patients sorted by age
Clinical characteristics in STE-ACS patients sorted by age and gender
are shown in Table 3. Younger patients had a history of priormyocardial
infarction, diabetes mellitus and hypertension less often, but had a his-
tory of cigarette smoking, hyperlipidemia and family history of coronary
heart disease more often. Time from symptom onset to hospital admis-
sion of more than 12 h was more frequent among older than younger
patients (34.7% versus 24.9%, (p b 0.001). Accordingly, time from symp-
tom onset to hospital admission of less than 6 h was more frequent in
younger (65.0%) than in older patients (53.2%).Hypertension 1846 (65.8) 1805 (80.8) b0.001
Current smoker 1473 (52.6) 469 (23.1) b0.001
Hyperlipidemia 1379 (55.2) 928 (46.4) b0.001
Cardiovascular history
Angina pectoris 356 (12.4) 416 (18.1) b0.001
Prior MI 516 (17.9) 491 (24.4) b0.001
Prior PCI 288 (10.0) 167 (7.3) b0.001
Prior stroke 28 (1.0) 75 (3.3) b0.001
Comorbidities
COPD 131 (4.8) 185 (8.4) b0.001
Renal diseases 94 (8.6) 129 (13.9) b0.001
Data are expressed as number (percentages).
CAD: coronary artery disease; COPD: chronic obstructive pulmonary disease; MI: myocar-
dial infarction; PCI: percutaneous coronary intervention.
Table 5
In hospital medications for patients with STE-ACS patients classified by age and gender.
Variable




















15.8 21.7 b0.001 29.6 35.2 0.004
p-PCI 78.6 74.2 0.013 67.4 60.8 b0.001
Fibrinolysis 2.6 1.2 0.111 1.5 2.7 0.043
Aspirina 97.0 96.0 0.026 95.9 92.0 b0.001
ACE inhibitorsa 76.2 74.6 0.380 79.5 73.5 b0.001
Beta blockersa 82.0 79.1 0.081 73.1 69.6 0.064
Clopidogrel 95.2 93.4 0.058 91.4 89.5 0.122
UFH 37.0 32.1 0.016 38.8 34.4 0.030
LMWH 55.0 53.0 0.345 56.1 50.9 0.013
Nitrates 19.3 22.0 0.113 34.3 26.1 b0.001
Statinsa 95.6 92.6 b0.001 87.7 87.5 0.885
Data are expressed as percentages.
ACE: angiotensin converting enzyme; LMWH: low molecular weight heparins; STE-ACS:
ST-segment elevation acute coronary syndromes; UFH: unfractioned heparins.
a Medications administered within 24 h of hospital admission.
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Sex differences in STE-ACS are shown in Table 4. Women had a his-
tory of priormyocardial infarction and smoking less often, but had a his-
tory of hypertension family history of coronary diseases and diabetes
mellitus more often. Women reached the hospital later than men.
Fewer women presented during the first 2 h after onset of symptoms.
There were no remarkable differences between the 2 age groups.
3.5. Treatment
Reperfusion therapy by primary PCI (Table 5) was performed in
74.2% of women and 78.6% of men in the age group of 65 years or less.
The number of interventions was markedly reduced in the age group
of more than 65 years, but sex difference still persisted (60.8% versus
67.4%). Interestingly, there were no differences in fibrinolysis between
sexes in the younger age group, but fibrinolysis was more frequently
used in women in the older group of patients. Yet, there were also sex
differences in the use of concomitant medical treatment with aspirin,
heparins, or angiotensin-converting enzyme inhibitors being given
less to women (Table 5).
3.6. Mortality rates
The overall in-hospital mortality rate was higher among women
than men (10.3% versus 6.9%; OR 1.56 95%CI 1.28–1.91 p b .001). Yet,
in STE-ACS there was a significant higher mortality in women in the
younger age group (age-adjusted OR 1.52, 95% CI: 1.01–2.29), but
there was no sex difference in the older group (adjusted OR 1.10, 95%
CI: 0.87–1.41). Significantly sex differences in mortality were not seen
in NSTE-ACS patients.
4. Discussion
Whether sex disparities in care processes and death after ACS are
still present in the current era of reperfusion therapy by primary PCI
and the extent to which differences in treatment may account for any
existing mortality rate gap remain a matter of debate. In addition,Table 4
Patients with STE-ACS compared by age and gender.






Typical chest pain 93.3 93.4
Killip Class N1 25.6 26.1
Time from symptom onset to admission
b2 h 33.1 29.3
2–6 h 33.0 32.5
6–12 h 9.5 11.6
12–24 h 10.7 11.8
N24 h 13.6 14.7
Risk factors
Hypertension 63.0 73.8
Diabetes mellitus 19.8 25.3
Family history of CAD 58.7 62.5
Current smoker 54.1 48.5
Hyperlipidemia 54.5 56.9
Cardiovascular history
Angina pectoris 11.5 14.8
Prior MI 18.5 16.3
Prior PCI 9.7 10.9
Prior stroke 1.0 0.9
Comorbidities
COPD 4.3 6.0
Renal diseases 2.7 3.5
Data are expressed as percentages.
CAD: coronary artery disease; COPD: chronic obstructive pulmonary disease; MI: myocardial inolder age and associated comorbidities have been suggested as a
major explanation of such disparities, but reasons for similar disparities
in younger patients have been less well studied [1,2,18,19]. We found
that the in-hospital mortality from ACS is not different between men
and women. A higher short-term mortality can be seen only in
women with STEMI of age of 65 years or less.
4.1. STE-ACS, reperfusion therapy and in-hospital mortality
Consistent with most previous investigations, younger women with
STEMI in our registry had a higher risk for hospital death than men [9,
10,20–23]. Less use of reperfusion therapy among older women
compared with men has been consistently reported by many studies
[18,24–27]. The reasons for youngerwomen not to be treated according
to guidelines are more impenetrable than in the elderly. Atypical









0.925 89.5 89.0 0.700
0.788 41.3 43.1 0.385
0.056 19.5 16.2 0.041
0.803 34.4 36.1 0.396
0.101 11.6 12.9 0.343
0.409 14.5 15.1 0.687
0.496 20.1 19.7 0.811
b0.001 76.9 85.5 b0.001
0.001 33.5 40.0 0.001
0.001 48.3 58.0 b0.001
0.008 29.0 16.0 b0.001
0.257 44.4 48.8 0.035
0.019 16.7 19.9 0.048
0.178 23.9 18.4 0.001
0.348 6.4 8.4 0.067
0.811 3.1 3.5 0.592
0.060 9.5 7.0 0.031
0.236 12.3 9.9 0.069
farction; PCI: percutaneous coronary intervention.
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cal symptoms are associated with patient delay in seeking medical at-
tention resulting in late diagnosis by both the emergency department
and local physicians [29,30]. In the Serbian data, atypical symptoms
were more frequent in the elderly, but there were no differences in
their presentation among women and men. Thus presentation with
atypical symptoms cannot be a factor for inequality in treatment. Never-
theless women in Serbia more often had a longer pre-hospital delay
than men, which suggest a high degree of awareness of the disease.
Patients themselves and the public healthcare sector need to be more
educated about the high risk of death experienced by women with
STE-ACS. More education may help to encourage earlier contact with
healthcare service.4.2. STE-ACS, risk factors and in-hospital mortality
Diabetes was also considered among the explanatory variables,
given the findings of a worse outcome in women with diabetes com-
pared with men with STE-ACS [21]. In both age groups, diabetes was
more prevalent in women. Diabetes was associated with less use of
reperfusion therapy but there was no interaction with sex implying
similar treatment in men and women.
The same considerations can be done for hypertension. In both age
groups, hypertension was more prevalent in women [20,21]. However,
even after controlling for traditional risk factors, sex disparities
persisted.4.3. STE-ACS and in-hospital mortality: unmeasured factors
The greater short term mortality for younger women suggests con-
tribution from unmeasured confounders. Such factors could include va-
sospastic disease, or microcirculatory disease, whichmay often occur in
womenwith nonobstructive coronary disease andmay result in waxing
andwaning of symptoms and partial resolution of ST-elevation [31–34].
All of these factors may, therefore confounding and may refrain physi-
cians from reperfusion therapy. The fact that most of the women with
vasospastic disease exhibit a disorder of the entire coronary arterial
tree is certainly in keeping with this hypothesis. Vasospastic disease
may result in inappropriate coronary constriction during increased
sympathetic drive [35] which, in turn, may lead to plaque disruption
or erosion. Vasospastic disease may also induce “transmural coronary
steal”, which describes the phenomenon that can occur when vasodila-
tion in the subepicardial layers lowers the perfusion pressure to the sub-
endocardial layers, a vascular bed in which flow is pressure-dependent
[36–38].4.4. Study limitations
Because we used data from 3 tertiary centers in Serbia, our datamay
not be representative of the country. Furthermore, the treatment
decisions were not randomized and were left to the discretion of the
treating physician.5. Conclusions
Our findings extend the previous literature, primarily based on US
patients [39], by showing significant gender differences in outcomes
by age in Serbia, a middle-income country with a large, potentially
very different patient population and with different challenges in
healthcare services. As we have shown, commonly cited clinical factors
do not entirely explain why reperfusion is being withheld, especially
among younger women. There is a strict relationship between lack of
reperfusion therapy and short term mortality.Conflict of interest
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